Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password
PMLiVE Top Pharma List

21

Revenue 2017

Biogen Idec

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Biogen Idec's 2013 Oncology and CNS sales performance.

Biogen Idec Inc.

Biogen to open compassionate use programme for ALS patients with ‘rapidly progressive disease’

Biogen to open compassionate use programme for ALS patients with ‘rapidly progressive disease’

This stage will come before the safety and efficacy of the drug are established, Biogen noted. ... The EAP for tofersen will start before Biogen submits applications for regulatory approval of the drug.

Biogen reveals new data for MS therapies Tysabri and Vumerity

Biogen reveals new data for MS therapies Tysabri and Vumerity In addition to the Tysabri data, Biogen also disclosed findings on the use of Vumerity (diroximel fumarate) in a real-world setting. ... with relapsing MS continue with treatment, which is essential to delay its progression,” said Maha Radhakrishnan,

Scribe Therapeutics continues to advance the development of its CRISPR platform and pipeline

Scribe Therapeutics continues to advance the development of its CRISPR platform and pipeline The company is already conducting a $400m research collaboration with Biogen to develop CRISPR-based therapies for Amyotrophic Lateral Sclerosis (ALS).

EU authorises Roche’s spinal muscular atrophy treatment Evrysdi

EU authorises Roche’s spinal muscular atrophy treatment Evrysdi Evrysdi becomes the third drug approved to treat the condition, following Biogen's Spinraza (nusinersen) and Novartis' Zolgensma (onasemnogene abeparvovec), and is the first that can be administered orally.

J&J’s MS drug ponesimod receives approval in the US

J&J’s MS drug ponesimod receives approval in the US As well as the newer therapies, a range of blockbuster drugs are already available for MS, including Biogen’s Tecfidera (dimethyl glutamate) and new injectables like Roche’s Ocrevus (ocrelizumab).

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Global Data

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....

Quick links